Abstract Search

ea0092ps2-15-09 | Hyperthyroidism | ETA2023

Long-term follow-up after antithyroid drug treatment withdrawal in patients with the first episode of graves` disease: a retrospective cohort study in spain

Meneses Diego , Sanchez Lechuga Begona , Velez Romero Maria , Sierra Poyatos Roberto , Vazquez Martinez Clotilde , Cardenas Salas Jersy

Background: Despite a high relapse rate, antithyroid drugs (ATDs) remain the first-line therapy of Graves disease (GD). Long-term follow-up studies of GD in Spain are scarce. Our aims were to identify clinical differences between patients who relapsed vs those who attained remission and to describe the relapse rate of GD after ATD withdrawal.Methods: We analyzed patients with the first episode of GD who were treated with ATDs during 2010 - 2020, in...

3 shares

ea0090p336 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Oral Semaglutide Improves Metabolic Outcomes in Type 2 Diabetes: A Spain-based Study

Casado Carlos , Jair Cardenas Salas Jersy , Miguel Sierra Poyatos Roberto , Montoya Alvarez Teresa , Meneses Gonzalez Diego , Gabriel Ruiz Sanchez Jorge , Luiza Luca Bogdana , Sanchez Lechuga Begona , de los Angeles Velez Romero Maria , Vazquez Martinez Clotilde

Objectives: To evaluate the changes in HbA1c, basal glucose, weight, and lipid profile in patients with type 2 diabetes after starting oral semaglutide.Methods: This study was conducted in Madrid, Fundación Jiménez Díaz, Infanta Elena and General de Villalba hospitals. A total of 75 patients with type 2 diabetes were included. The mean age was 62.0&pm;10.5 years and 60% were men. The mean duration of diabetes was 7.3&pm;6.6 years, and 66.7...

1 shares

Endocrine Abstracts

Long-term follow-up after antithyroid drug treatment withdrawal in patients with the first episode of graves` disease: a retrospective cohort study in spain

Oral Semaglutide Improves Metabolic Outcomes in Type 2 Diabetes: A Spain-based Study

BiosciAbstracts